Open house drug discount agreements Liraglutid, ATC A10BJ02
Original notice title
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Liraglutid, ATC A10BJ02
Opportunity Score
Why this score?
Opportunity
50 / 100
Complexity
30 / 100
Risk factors
Submission requirements are strict: paper submissions must be in duplicate original, and electronic submissions require...
The open-house model is not subject to procurement law, but recourse is to social courts rather than procurement tribun...
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Overview
Moderate opportunityKey Facts
- Framework procurement
- Supplies contract
- 1 lot
- Duration until Jun 2027
- Enter into a non-exclusive discount agreement with AOK Bayern for Liraglutid (ATC A10BJ02)
- Supply the pharmaceutical product under the agreed discount terms
Show full summary
This is an open-house model for non-exclusive drug discount agreements on Liraglutid (ATC A10BJ02) offered by AOK Bayern. All eligible pharmaceutical companies can participate. The contract runs from 01.07.2025 to 30.06.2027, with a rolling submission deadline until 05.05.2027. No selection is made; all qualifying applicants receive a contract. The procedure is not subject to procurement law.
Risks
Submission requirements are strict: paper submissions must be in duplicate original, and electronic submissions require...
The open-house model is not subject to procurement law, but recourse is to social courts rather than procurement tribun...
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Technical
- Must be a pharmaceutical company (pharmazeutischer Unternehmer)
Administrative
- Submit a signed declaration of reliability (Eigenerklärung zur Zuverlässigkeit)
- Submit the signed contract and annex 'Festlegung der vertragsgegenständlichen Arzneimittel'
Requirements may be incomplete.
Buyer
Location
München, DEU
Website
Buyer profile
Identifier
DE811695320
Activity
Health
Lots (1)
LOT-0001
Open house drug discount agreements Liraglutid, ATC A10BJ02
Non-exclusive discount agreement for the active substance Liraglutid, ATC code A10BJ02. The contract is open to all pharmaceutical companies that meet the eligibility criteria.
Location
Duration
Category
Deadline
Award details
Siehe kurze Beschreibung ACHTUNG: Die Vertragsunterlagen sind zwingend über den Kommunikationsbereich im Vergabeportal www.dtvp.de einzureichen und keinesfalls über den Angebotsbereich!
Value note
Show original TED data
Original lot title
Open house Arzneimittelrabattverträge Liraglutid, ATC A10BJ02
Original TED description
Siehe kurze Beschreibung ACHTUNG: Die Vertragsunterlagen sind zwingend über den Kommunikationsbereich im Vergabeportal www.dtvp.de einzureichen und keinesfalls über den Angebotsbereich!
Procurement Details
- Publication date
- 15 May 2025
- Languages
- German
Reference metadata
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 315079-2025
Documents (2)
Similar tenders
Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)
Denmark – Pharmaceutical products – Amgros 2027 1.1170.a
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)
Germany – Pharmaceutical products – Open House Biologika Rabattverträge 2026 - 27 - Follitropin delta
Opportunity Score
Why this score?
Opportunity
50 / 100
Complexity
30 / 100
Risk factors
Submission requirements are strict: paper submissions must be in duplicate original, and electronic submissions require...
The open-house model is not subject to procurement law, but recourse is to social courts rather than procurement tribun...
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications